Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes mellitus, continue to be the more important prognostic factors in determining survival, and so the search for effective anti‐fibrotic interventions is an important target for research and therapy in cardiology.
Anna Krzyżewska +2 more
wiley +1 more source
Prevalence of pediatric cannabidiol prescribing in the United States. [PDF]
Li Y +12 more
europepmc +1 more source
Adherence to Consolidated Standards of Reporting Trials (CONSORT) guidelines for reporting safety outcomes in trials of cannabinoids for chronic pain: Protocol for a systematic review [PDF]
Campbell, Fiona +6 more
core +1 more source
ABSTRACT Issues Higher delta‐9‐tetrahydrocannabinol (THC) concentration medicinal cannabis products are characterised by a higher THC and minimal cannabidiol (CBD) content. This rapid review aims to systematically summarise and evaluate the available evidence regarding the efficacy and safety of higher THC potency medicinal cannabis products relevant ...
Myfanwy Graham +3 more
wiley +1 more source
Clinical Study to Evaluate Drug Interactions of Cannabidiol with Citalopram and Morphine in Healthy Adults. [PDF]
Salcedo P +11 more
europepmc +1 more source
Microvascular Effects of Endocannabinoid Signaling in Sepsis: A Mechanistic and Systematic Review
ABSTRACT Microvascular dysfunction is a central determinant of organ failure in sepsis, reflecting early endothelial activation, increased permeability, and impaired capillary perfusion. Experimental evidence suggests that the endocannabinoid system (ECS) modulates these immunovascular processes, yet mechanistic insights remain dispersed across ...
Emanuel F. Matias +2 more
wiley +1 more source
Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population. [PDF]
Fatakhova K +10 more
europepmc +1 more source
Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru<sup>®</sup>, vs an Oil-Based Formulation, Epidyolex<sup>®</sup>, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study. [PDF]
Bendik I +13 more
europepmc +1 more source

